These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 35763685)

  • 1. The impact of infection with COVID-19 on the respiratory microbiome: A narrative review.
    Zhu T; Jin J; Chen M; Chen Y
    Virulence; 2022 Dec; 13(1):1076-1087. PubMed ID: 35763685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19.
    S A; K G; A AM
    J Biomol Struct Dyn; 2022; 40(24):14262-14278. PubMed ID: 34699326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.
    Tieu V; Tibi S; Ling J
    Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
    Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
    Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between immune system and microbiota in COVID-19.
    Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Connection between Gut and Lung Microbiota, Mast Cells, Platelets and SARS-CoV-2 in the Elderly Patient.
    Traina G
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    Wu J; Liu W; Zhu L; Li N; Luo G; Gu M; Peng M; Zeng S; Wu S; Zhang S; Chen Q; Cai M; Cao W; Jiang Y; Luo C; Tian D; Shi M; Shu Y; Chang G; Luo H
    J Med Virol; 2023 Apr; 95(4):e28727. PubMed ID: 37185870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    de Castilhos J; Zamir E; Hippchen T; Rohrbach R; Schmidt S; Hengler S; Schumacher H; Neubauer M; Kunz S; Müller-Esch T; Hiergeist A; Gessner A; Khalid D; Gaiser R; Cullin N; Papagiannarou SM; Beuthien-Baumann B; Krämer A; Bartenschlager R; Jäger D; Müller M; Herth F; Duerschmied D; Schneider J; Schmid RM; Eberhardt JF; Khodamoradi Y; Vehreschild MJGT; Teufel A; Ebert MP; Hau P; Salzberger B; Schnitzler P; Poeck H; Elinav E; Merle U; Stein-Thoeringer CK
    Clin Infect Dis; 2022 Aug; 75(1):e1063-e1071. PubMed ID: 34694375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nutrients in modulating microbiota and immunity in COVID-19 disease.
    Di Renzo L; Gualtieri P; Rio P; Massaro MG; Caldarelli M; Frank G; Della-Morte D; Gasbarrini A; Gambassi G; De Lorenzo A; Franza L; Cianci R
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5927-5945. PubMed ID: 37401330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
    Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
    World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.